Related Experiment Video
Updated: May 10, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Diarrhoea in irradiated patients: a prospective multicentre observational study
Stefano Pergolizzi1, Ernesto Maranzano, Verena De Angelis
1Radiotherapy Centre, "G. Martino" University Hospital, Messina, Italy.
Cancer treatment-induced diarrhea affects 14.6% of patients undergoing irradiation. Abdominal-pelvic cancer patients treated with curative intent and large radiation fields face the highest risk, requiring closer monitoring.
Area of Science:
- Oncology
- Radiation Therapy
- Gastroenterology
Background:
- Diarrhea is a common side effect of cancer treatment, impacting patient quality of life.
- Understanding the incidence and risk factors for radiation-induced diarrhea is crucial for effective patient management.
Purpose of the Study:
- To determine the incidence of cancer treatment-induced diarrhea in patients undergoing irradiation.
- To identify predictors of diarrhea development during and after radiotherapy.
Main Methods:
- Prospective observational study involving 1020 patients across 45 Italian radiation oncology departments.
- Daily diary cards recorded diarrhea onset and intensity during and one week post-radiotherapy.
- Multivariate analysis identified significant predictors of diarrhea.
Main Results:
- 14.6% of 1004 eligible patients experienced diarrhea.
- Significant predictors included primitive tumor site, therapeutic purpose (curative intent), and radiation field size.
- 56.2% of patients with diarrhea received medication.
Conclusions:
- Patients with abdominal-pelvic cancer receiving curative radiotherapy with large fields are at high risk.
- Diarrhea incidence necessitates more stringent monitoring protocols for at-risk patient groups.
- Further research may explore targeted interventions to mitigate this side effect.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Lower GI Series: Barium Enema
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
